ENPP1 Modulators and Uses Thereof - VIR Biotechnology
Summary
The European Patent Office published patent application EP4149927A1 for ENPP1 modulators and their therapeutic uses, filed by VIR Biotechnology, Inc. of San Francisco, California. The application covers compounds within International Patent Classification C07D (heterocyclic compounds) with therapeutic applications including anti-infectives (A61P 31/00) and anti-neoplastics (A61P 35/00). The A1 publication includes the EPO search report and opens a six-month window for third-party observations before the examination phase. The application designates all 35+ EPC contracting states across the EU and beyond.
About this source
GovPing monitors EPO Patent Bulletin - Organic Chemistry (C07D) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 63 changes logged to date.
What changed
The EPO published patent application EP4149927A1, a new filing for ENPP1 (ectonucleotide pyrophosphatase/phosphodiesterase 1) modulator compounds and their pharmaceutical uses, designating all EPC contracting states. The A1 publication kind indicates the application is now publicly accessible with the attached EPO search report, initiating the pre-grant observation phase. No amendments to existing rights are involved — this is a new application entry into the EPO register.
Competitors developing ENPP1-targeted therapeutics should review this publication during the observation period to assess potential overlaps with their own compound families or use claims. Generic and biosimilar developers tracking VIR Biotechnology's pipeline will find the designated states (covering all major European markets), IPC codes (C07D 215/233, 215/42, 239/94), and therapeutic classifications (A61P 31/00, 35/00) useful for freedom-to-operate analysis.
Archived snapshot
Apr 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
ENPP1 MODULATORS AND USES THEREOF
Publication EP4149927A1 Kind: A1 Apr 15, 2026
Applicants
VIR Biotechnology, Inc.
Inventors
SAITO, Roland D., TSE, Winston C.
IPC Classifications
C07D 215/233 20060101AFI20211119BHEP C07D 215/42 20060101ALI20211119BHEP C07D 239/94 20060101ALI20211119BHEP A61P 31/00 20060101ALI20211119BHEP A61P 35/00 20060101ALI20211119BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Organic Chemistry (C07D) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.